- Išparduota
/https://libri-media.knygos-static.lt/b35f69c1-d8c8-46bc-a4e6-c333c28d081c/1)
- Leidėjas: Taylor & Francis Ltd.
- Metai: 2017
- Puslapiai: 487
- ISBN: 9781351646185
- ISBN-10: 1351646184
- ISBN-13: 9781351646185
- Formatas: ACSM ?
- Kalba: Anglų
Biosimilar Drug Product Development (el. knyga) (skaityta knyga) | knygos.lt
Atsiliepimai
Formatai:
Aprašymas
When a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. Biosimilar Drug Product Development presents current issues for the development of biosimilars and gives detailed reviews of its various stages and contributing factors as well as relevant regulatory pathways and pre- and post-approval issues.
Elektroninė knyga:
Atsiuntimas po užsakymo akimirksniu! Skirta skaitymui tik kompiuteryje, planšetėje ar kitame elektroniniame įrenginyje.
Kaip skaityti el. knygas ACSM formatu?
Mažiausia kaina per 30 dienų: 154,79 €
Mažiausia kaina užfiksuota: 2026-06-01 00:03:17
- Leidėjas: Taylor & Francis Ltd.
- Metai: 2017
- Puslapiai: 487
- ISBN: 9781351646185
- ISBN-10: 1351646184
- ISBN-13: 9781351646185
- Formatas: ACSM ?
- Kalba: Anglų
When a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. Biosimilar Drug Product Development presents current issues for the development of biosimilars and gives detailed reviews of its various stages and contributing factors as well as relevant regulatory pathways and pre- and post-approval issues.
Atsiliepimai